HC Wainwright Reiterates Buy Rating for Veru (NASDAQ:VERU)

Veru (NASDAQ:VERU)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research report issued on Thursday,Benzinga reports. They currently have a $3.00 target price on the stock. HC Wainwright’s price objective indicates a potential upside of 306.78% from the company’s current price.

Separately, Oppenheimer reaffirmed an “outperform” rating and set a $5.00 price target on shares of Veru in a research report on Tuesday, November 5th.

Veru Stock Up 13.1 %

Shares of VERU stock opened at $0.74 on Thursday. Veru has a 12-month low of $0.36 and a 12-month high of $1.92. The firm has a 50 day moving average price of $0.70 and a two-hundred day moving average price of $0.80. The company has a market capitalization of $107.96 million, a PE ratio of -1.54 and a beta of -0.53.

Veru (NASDAQ:VERU) last released its quarterly earnings results on Monday, December 16th. The company reported ($0.06) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.01. Veru had a negative return on equity of 115.99% and a negative net margin of 376.38%. As a group, research analysts expect that Veru will post -0.3 EPS for the current year.

Institutional Investors Weigh In On Veru

A number of large investors have recently bought and sold shares of the company. Zacks Investment Management acquired a new stake in shares of Veru in the 3rd quarter valued at $25,000. Gladstone Institutional Advisory LLC boosted its stake in Veru by 34.2% in the third quarter. Gladstone Institutional Advisory LLC now owns 56,876 shares of the company’s stock valued at $44,000 after buying an additional 14,500 shares in the last quarter. SG Americas Securities LLC grew its position in Veru by 185.9% in the third quarter. SG Americas Securities LLC now owns 66,128 shares of the company’s stock valued at $51,000 after acquiring an additional 42,997 shares during the last quarter. Jane Street Group LLC grew its position in Veru by 142.8% in the third quarter. Jane Street Group LLC now owns 96,454 shares of the company’s stock valued at $74,000 after acquiring an additional 56,736 shares during the last quarter. Finally, Rhumbline Advisers raised its stake in Veru by 3,994.8% during the second quarter. Rhumbline Advisers now owns 113,632 shares of the company’s stock worth $96,000 after acquiring an additional 110,857 shares in the last quarter. 47.16% of the stock is currently owned by institutional investors and hedge funds.

About Veru

Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.